Literature DB >> 10738645

Multivariate methods in developing an evolutionary strategy for tablet formulation.

J Gabrielsson1, A Nyström, T Lundstedt.   

Abstract

The aim of this study was to develop a new strategy for choosing excipients in tablet formulation. Multivariate techniques such as principal component analysis (PCA) and experimental design were combined in a multivariate design for screening experiments. Of a total 87 investigated excipients, the initial screening experiments contained 5 lubricants, 9 binders, and 5 disintegrants, and 35 experiments were carried out. Considering a reduced factorial design was used, the resulting PCA and partial least squares (PLS) models offered good insight into the possibilities of tablet formulation. It also offered solutions to the problems and clearly gave directions for optimum formulations. Further, it offered several alternatives for achieving quality formulations. Additional experiments conducted to validate and verify the usefulness of the model were successful, resulting in several tablets of good quality. The conclusion is that a multivariate strategy in tablet of formulation is efficient and can be used to reduce the number of experiments drastically. Combining multivariate characterization, physicochemical properties, experimental design, multivariate design, and PLS would lead to an evolutionary strategy for tablet formulation. Since it includes a learning strategy that continuously incorporates data for new compounds and from conducted experiments, this would be an even more powerful tool than expert systems.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738645     DOI: 10.1081/ddc-100100356

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  1 in total

1.  Rapid development and optimization of tablet manufacturing using statistical tools.

Authors:  Eutimio Gustavo Fernández; Silvia Cordero; Malvina Benítez; Iraelio Perdomo; Yohandro Morón; Ada Esther Morales; Milagros Gaudencia Arce; Ernesto Cuesta; Juan Lugones; Maritza Fernández; Arturo Gil; Rodolfo Valdés; Mirna Fernández
Journal:  AAPS PharmSciTech       Date:  2008-05-06       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.